We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Avacta Sponsors 5th Annual Protein Formulation Development and Drug Delivery Forum

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Avacta Analytical has announced its sponsorship of this year’s Protein Formulation Development and Drug Delivery Forum in Barcelona, Spain.

Now in its fifth year, this exciting event runs from the 9th to the 11th of June, and will bring together research scientists from across the pharmaceutical and biotechnology sectors to explore current issues in protein formulation.

Protein formulation has become a highly important area of research for the pharmaceutical industry, and there is now increasing pressure to optimize drug formulations earlier in the development process to help avoid downstream failures and accelerate time-to-market.

This event will look at the latest innovations in protein formulation and drug delivery, highlighting recent research and technological advances - as well as updates to the regulatory framework - which can help to streamline and simplify formulation development activities.

Avacta will be showcasing the low volume protein characterization capabilities of the Optim 2 instrument at the event, giving delegates the opportunity to discuss how the system could help benefit their research with the Company’s technical experts.

Avacta’s Dr Geoff Platt will also be hosting a seminar entitled: ‘Strategy for stability assessment of antibodies: high throughput screening as a predictive tool for accelerating development’, providing practical examples of how novel technologies such as the Optim system can reduce the time and cost of therapeutic protein preformulation studies, protein stability testing and formulation development.